Finance

Lists
OWLT:NYSE
Owlet Inc
USD 5,06
+0,60%
(+0,030) 1D
2 Okt., 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OWLT...
Open
USD 5,14
High
USD 5,20
Low
USD 5,01
Mkt. cap
147,86 m
Avg. vol.
220,68 k
Volume
82,94 k
52-wk high
USD 16,94
52-wk low
USD 4,19
EPS
-USD 0,46
Beta
1,90
Shares outstanding
29,22 m
No. of employees
111
Open
USD 5,14
High
USD 5,20
Low
USD 5,01
Mkt. cap
147,86 m
Avg. vol.
220,68 k
Volume
82,94 k
52-wk high
USD 16,94
52-wk low
USD 4,19
EPS
-USD 0,46
Beta
1,90
Shares outstanding
29,22 m
No. of employees
111
News stories
From web sources and news partners
About Owlet Inc
CEO-
Employees111
Founded2013
Headquarters-
SectorMedical device
Websiteowletcare.com
Analyst ratings
Based on 4 analysts giving stock ratings to OWLT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OWLT in the last 3 months.
Highest
Current USD 5,06
USD 14,00 (+176,68%)
Average
USD 12,33 (+143,68%)
Lowest
USD 10,00 (+97,63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Steven Lichtman
William Blair
Buy
Maintained
-
-
09/25/2026
Owen Rickert
Northland Securities
Buy
Maintained
USD 13,00
+156,9%
09/23/2026
Jonna Kim
TD Cowen
Buy
Reiterated
USD 10,00
+97,6%
08/13/2026
Ben Haynor
Lake Street
Buy
Reiterated
USD 14,00
+176,7%
08/10/2026
Oliver Chen
TD Cowen
Buy
Reiterated
USD 10,00
+97,6%
06/22/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/08/2026
Last report
11 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 0,20 / -USD 0,02
+900,00%beat
Revenue / Est. (USD)
33,86 m / 31,72 m
+6,76%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
31,99 m
26,55 m
22,46 m
33,86 m
Cost of goods sold
15,79 m
13,93 m
10,22 m
12,04 m
Cost of revenue
15,79 m
13,93 m
10,22 m
12,04 m
Research and development expenses
3,78 m
3,64 m
3,96 m
4,56 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,20 m
13,88 m
13,77 m
15,52 m
Operating expense
14,98 m
17,51 m
17,73 m
20,08 m
Total operating expenses
30,77 m
31,44 m
27,95 m
32,12 m
Operating income
1,22 m
-4,89 m
-5,49 m
1,74 m
Other non operating income
3,79 m
-3,74 m
2,85 m
566,00 k
EBT including unusual items
4,14 m
-9,22 m
-3,33 m
-610,00 k
EBT excluding unusual items
4,14 m
-9,22 m
-3,33 m
1,60 m
Income tax expense
9,00 k
-26,00 k
7,00 k
10,00 k
Effective tax rate
0,22%
0,28%
-0,21%
-1,64%
Other operating expenses
-
-
-
-
Net income
4,13 m
-9,19 m
-3,34 m
-620,00 k
Net profit margin
12,92%
-34,61%
-14,86%
-1,83%
Earnings per share
0,03
-0,03
-0,09
0,20
Interest and investment income
-
-
-
-
Interest expense
-860,00 k
-588,00 k
-683,00 k
-707,00 k
Net interest expenses
-860,00 k
-588,00 k
-683,00 k
-707,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
1,27 m
-4,83 m
-5,43 m
1,81 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme